Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dis-Chem PharmaciesJSE:DCP -1.58%79 Earnings Yield (Joel Greenblatt) % is 5.15% as of Feb. 2026, which is 3% below its 10-year median of 5.32. GuruFocus rates JSE:DCP with a GF Score™ of 79/100 and a GF Value™ of R38.70 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 679 Healthcare Providers & Services companies, Dis-Chem Pharmacies ranks better than 67.01% on this metric.
Dis-Chem Pharmacies's Enterprise Value for the quarter that ended in Feb. 2026 was R37,863 Mil.
Dis-Chem Pharmacies's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 was R1,949 Mil. Dis-Chem Pharmacies's Earnings Yield (Joel Greenblatt) for the quarter that ended in Feb. 2026 was 5.15%.
The historical rank and industry rank for Dis-Chem Pharmacies's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
JSE:DCP'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 2.65 Med: 5.32 Max: 7.42
Current: 6.46
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Dis-Chem Pharmacies was 7.42%. The lowest was 2.65%. And the median was 5.32%.
JSE:DCP's Earnings Yield (Joel Greenblatt) % is ranked better than 67.01% of 679
companies
in the Healthcare Providers & Services industry
Industry Median: 3.82
vs JSE:DCP: 6.46
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Dis-Chem Pharmacies's Forward Rate of Return (Yacktman) % for the quarter that ended in Feb. 2026 was 11.30%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Dis-Chem Pharmacies Earnings Yield (Joel Greenblatt) % Related Terms
Dis-Chem Pharmacies Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Dis-Chem Pharmacies's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dis-Chem Pharmacies Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Dis-Chem Pharmacies's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Dis-Chem Pharmaciess Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Feb. 2026 is calculated as
For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.
What does a Earnings Yield (Joel Greenblatt) % of 5.15% mean?
Dis-Chem Pharmacies (JSE:DCP) has a Earnings Yield (Joel Greenblatt) % of 5.15% as of Feb. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Dis-Chem Pharmacies and its competitors. This is near median its historical median of 5.32. Over the past decade, Dis-Chem Pharmacies' Earnings Yield (Joel Greenblatt) % has ranged from 2.65 to 7.42. According to the industry distribution chart, Dis-Chem Pharmacies ranks #224 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 33%.
Is Dis-Chem Pharmacies' Earnings Yield (Joel Greenblatt) % too high?
Dis-Chem Pharmacies' current Earnings Yield (Joel Greenblatt) % of 5.15% is near median its 10-year median of 5.32. Over the past 10 years, this metric has ranged from a low of 2.65 to a high of 7.42. The Healthcare Providers & Services industry median Earnings Yield (Joel Greenblatt) % is 3.82. Dis-Chem Pharmacies' value of 5.15% is 34.8% above this industry median. Based on the distribution chart, Dis-Chem Pharmacies ranks #224 out of 679 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dis-Chem Pharmacies has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dis-Chem Pharmacies' Earnings Yield (Joel Greenblatt) % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Dis-Chem Pharmacies ranks #224 out of 679 companies for Earnings Yield (Joel Greenblatt) %. This puts Dis-Chem Pharmacies in the upper half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.82. Dis-Chem Pharmacies' value of 5.15% is 34.8% above this benchmark. Historically, Dis-Chem Pharmacies' own Earnings Yield (Joel Greenblatt) % has ranged from 2.65 to 7.42 over the past decade. While the company's 10-year median is 5.32 vs. the industry median of 3.82, Dis-Chem Pharmacies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.82, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dis-Chem Pharmacies's current Earnings Yield (Joel Greenblatt) % of 5.15% is 34.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Dis-Chem Pharmacies and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dis-Chem Pharmacies's current Earnings Yield (Joel Greenblatt) % is 5.15%, which is near median its own 10-year median of 5.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dis-Chem Pharmacies stock overvalued right now?
Based on GuruFocus' analysis, Dis-Chem Pharmacies (JSE:DCP) is currently considered Modestly Undervalued. The stock's GF Value™ is R38.70, compared to a current price of R28.02 — trading 27.6% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 5.15%, which is near median its 10-year median of 5.32 and 34.8% above the Healthcare Providers & Services industry median of 3.82. Dis-Chem Pharmacies' overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Dis-Chem Pharmacies (JSE:DCP), the current Earnings Yield (Joel Greenblatt) % is 5.15% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dis-Chem Pharmacies (JSE:DCP) Overvalued in 2026?
Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued.
The current stock price of R28.02 is trading 27.6% below its estimated GF Value™ of R38.70.
GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.
Key valuation signals for JSE:DCP:
Earnings Yield (Joel Greenblatt) %: 5.15% (near median its 10-year median of 5.32)
GF Value™: R38.70 vs. price of R28.02 (27.6% below fair value)
Industry Position: 34.8% above the Healthcare Providers & Services median (#224 of 679)
No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
79GF Score
Get the complete analysis for JSE:DCP
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:DCP has been successfully added to your 
